S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Home › WELL › Research report
← WELL page
XStocksXray
Research report · 16 October 2026

Welltower Inc. (WELL)

Real Estate · Health Care REITs · US stock · price as of 16 Oct 2026

Key indicators

Price$234.85
52-week range$168.77 – $254.24
Market cap$170.6B
P/E (trailing)113.1×
EV / EBITDA–
Free-cash-flow yield1.7%
Dividend yield1.3%
Revenue (last 12 months)$11.8B
Revenue growth (3y a year)22.7%
Operating margin–
Return on invested capital–
Net debt / EBITDA–

Fair value

Fair value is not shown for this company.

X-Ray Score

47/ 100 · Low confidence · ahead of 34% of sector peers
Valuation10
Growth90
Profitability35
Financial health69
Dividends41

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

40.4796.111522072632021-102023-012024-042025-072026-10

Executive summary

Welltower is a real estate investment trust that owns health care and senior living properties, including senior housing communities, outpatient medical buildings and some long-term care facilities. It earns income from rents and from operating partnerships in which residents pay for housing and care. The company invests in properties across North America and the United Kingdom, and its results are linked to demographic trends and occupancy at its communities.

Trailing twelve-month revenue stands at $9.4 billion, while revenue grew by 26.5% a year over the past three years. The company pays a dividend, and the yield is 1.3%.

StocksXray gives Welltower Inc. an X-Ray Score of 47 out of 100 (low confidence), ahead of 34% of the S&P 500 stocks in its sector. Its strongest lens is growth (90) and its weakest is valuation (10).

stocksxray.com · page 1
XStocksXray
Welltower Inc. (WELL)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$76.63$60.40$85.65$122.54$183.63$234.85
Market cap$32.7B$28.1B$44.4B$74.6B$124.8B$170.6B
P/E98.2×201.3×129.8×78.1×132.1×113.1×
EV / revenue10.0×7.3×8.9×10.9×12.9×15.7×
EV / EBITDA27.9×21.3×24.9×40.3×––
Price / free cash flow25.6×21.1×27.7×33.1×43.3×57.8×
Free-cash-flow yield3.9%4.7%3.6%3.0%2.3%1.7%
Price / book1.9×1.4×1.7×2.3×3.0×3.9×
Dividend yield3.18%4.04%2.85%2.09%1.54%1.31%

Fundamentals checklist ● 4 Good · ● 0 Average · ● 2 Bad · each check graded against the sector

Cash quality

Earnings backed by cash−2.3%Bad

Risk models

Piotroski F-Score7 of 9Good

Growth

EPS growth (3y)66.7%Good
Revenue growth (3y)22.7%Good
Growth consistency100%Good

Profitability

Gross profitability7.0%Bad

Red flags

  • Heavy dilution — Share count up more than 5% year on year
stocksxray.com · page 2
XStocksXray
Welltower Inc. (WELL)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue4,7425,8616,6387,99110,83811,767
Gross profit1,9682,3022,6903,1614,3504,686
Operating income661703958524––
Net income3361413409529371,432
Diluted EPS ($)0.780.300.661.571.392.08
Free cash flow1,2751,3291,6022,2562,8822,953
Gross margin41.5%39.3%40.5%39.6%40.1%39.8%
Operating margin13.9%12.0%14.4%6.6%––
Net margin7.1%2.4%5.1%11.9%8.6%12.2%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets34,91037,89344,01251,04467,30367,221
Cash2696321,9943,5075,0344,704
Total debt13,91014,71415,73615,50019,19717,934
Equity17,63620,29525,40431,95642,12943,794
Dividend per share ($)2.442.442.442.562.822.89

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%14%28%41%FY21FY22FY23FY24FY25

Latest quarters

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ($M)2,2512,4232,5482,6863,1813,352
Growth vs a year earlier+28.6%+30.3%+39.6%+30.6%+41.3%+38.3%
Net income ($M)10325730528293752
Diluted EPS ($)–0.400.450.41–1.02
stocksxray.com · page 3
XStocksXray
Welltower Inc. (WELL)

Peers in Health Care REITs

CompanyX-Ray
WELL · Welltower Inc.47
VTR · Ventas, Inc.47
DOC · Healthpeak Properties, Inc...37

Market Compass outlook for Real Estate: Unfavourable (20/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+4.2%
1 month+1.1%
3 months−3.7%
6 months+12.4%
1 year+38.3%
3 years+190.2%
5 years+220.2%

Technical summary

DailyBullish11 bullish · 1 neutral · 4 bearish
WeeklyStrongly bullish10 bullish · 1 neutral · 1 bearish
MonthlyStrongly bullish7 bullish · 0 neutral · 1 bearish
50-day / 200-day average$233.38 / $215.05
52-week low / high$168.77 / $254.24
Classic pivot, support and resistanceS2 231.77 · S1 233.31 · P – · R1 236.81 · R2 238.77

Recent dividends

Ex-dividend dateAmount per share
12 Aug 2026$0.8500
13 May 2026$0.7400
25 Feb 2026$0.7400
10 Nov 2025$0.7400
12 Aug 2025$0.7400
14 May 2025$0.6700
stocksxray.com · page 4
XStocksXray
Welltower Inc. (WELL)

Strengths

  • Revenue growth of 22.7% a year over three years is ahead of 98% of its sector peers.
  • Piotroski F-Score of 7 out of 9: most of the nine accounting health tests pass.

Risks and weak spots

  • Earnings backed by cash is weak against Real Estate peers (−2.3%).
  • Gross profitability is weak against Real Estate peers (7.0%).
  • Red flag: Heavy dilution (Share count up more than 5% year on year).

Latest SEC filings

DateFormItems
28 Jul 20268-K8.01,9.01
28 Jul 2026424B5
28 Jul 202610-Q
27 Jul 20268-K2.02,9.01
13 Jul 20268-K8.01,9.01
8 Jul 2026424B5
6 Jul 2026424B5
1 Jun 20268-K7.01,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 19 Oct 2026